Becton Dickinson said on Wednesday its board has authorized a plan to separate its life sciences unit as the medical device maker aims to focus on its core business.

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Blockbuster Keytruda makes up nearly half of Merck’s sales. That’s becoming an issue.

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of ...

In the pursuit of the extraordinary, the novel, and the unexpected, science and math at RIT blends a passion for research, the practical application of theory, and the active pursuit of new ...

Nitat Termmee / Getty Images While you should enjoy everything life has to offer, it’s important to plan for what will happen when you die. If you have dependents who rely on your income ...